Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Evox Therapeutics

Evox Therapeutics
2016 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Grant LATEST DEAL TYPE
$1.98M LATEST DEAL AMOUNT
10 INVESTORS
Description

Developer of exosome-based therapeutics designed to treat various severe diseases with limited options for patients and their families. The company's therapeutics use nucleic acid and protein delivery technology, enabling users to leverage proprietary targeting technology, manufacturing processes and purification methods.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • Oxford Science Park, Medawar Centre
  • 2nd Floor East Building, Robert Robinson Avenue
  • Oxford OX4 4HG
  • England, United Kingdom

+44 01865 000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Evox Therapeutics’s full profile, request a free trial.

Evox Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 22-Mar-2019 $1.98M 000.00 Completed Generating Revenue
3. Grant 13-Nov-2018 00000 000.00 Completed Generating Revenue
2. Early Stage VC (Series B) 03-Sep-2018 $45.6M $60.2M 000.00 Completed Generating Revenue
1. Seed Round 10-May-2016 $14.6M $14.6M 0000 Completed Clinical Trials - Phase 1
To view this company’s complete deal history including valuation and funding, request access »

Evox Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
A Preferred 000,000 00.000000 00 0000.0 0000.0 00 0000.0 00.000
Ordinary 000,000 00.000000 00 000.00 000.00 00 000.00 00.000
To view this company’s complete Cap Table, request access »

Evox Therapeutics Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Codiak Venture Capital-Backed Cambridge, MA 00 00000 00000000
000000 00000000000 Venture Capital-Backed Cambridge, MA 0 0000 00000000000 0000
0000000 (000000000 Venture Capital-Backed Cambridge, MA 00 0000 00000000000 0000
0000000 0000000000 Venture Capital-Backed New York, NY 0 00000 0000000000 00000
00000000 Venture Capital-Backed Seattle, WA 0000 00000000000 0000
To view this company’s complete list of competitors, request access »

Evox Therapeutics Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Innovate UK Government 000 0000 000000 0
Duchenne UK Other 000 0000 000000 0
Bill & Melinda Gates Foundation Not-For-Profit Venture Capital Minority 000 0000 000000 0
Borealis Ventures Venture Capital Minority 000 0000 000000 0
Cowen Healthcare Investments Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »

Evox Therapeutics Executive Team (4)

Name Title Board
Seat
Contact
Info
Antonin de Fougerolles Ph.D Chief Executive Officer & Board Member
Per Lundin Ph.D Co-Founder, Chief Operating Officer & Board Member
Matthew Wood MD Co-Founder & Board Member
Samir El-Andaloussi Co-Founder

Evox Therapeutics Board Members (8)

Name Representing Role Since Contact
Info
Adam Stoten Self Board Member 000 0000
Amrit Nagpal Redmile Group Board Member 000 0000
Andrew McLean MD Oxford Sciences Innovation Board Member 000 0000
Antonin de Fougerolles Ph.D Evox Therapeutics Chief Executive Officer & Board Member 000 0000
Edwin Moses Ph.D Self Chairman 000 0000
You’re viewing 5 of 8 board members. Get the full list »